California Resources Corp (CRC): what the price assumes

In the published model solve dated 2026-Q2, anchored at $52.23, California Resources Corp (CRC) is priced for -1.7% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-25.

Generated: 2026-08-30 · Source: https://boothcheck.com/report/CRC

Headline

FieldValue
TickerCRC
CompanyCalifornia Resources Corp
Sector / IndustryEnergy
Current price$52.23/sh

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin (value-band context)5.2%
Operating margin (mid-cycle)16.3%
Margin compression (value-band)-11.1pp
Trailing margin (depressed year)-1.7%
Implied growth-1.7%
Multiple paid11x mid-cycle operating income

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 9.1% cost of capital with 4% terminal growth over a 5-year stage.

How unusual the bet is: n/a

ReferenceValue
vs own history-0.46σ

Valuation X-Ray

The price is supported by earnings-power value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.36x3expensive
Earnings1.24x2expensive
Relative0
Growth1.34x4expensive

Families that justify the price: Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.5%); the inversion above states its own rate.

Per-Model Detail (n=9)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$46.231.13xyesFCF base $0.4B, growth 0% (input: historical growth), terminal g 0.5%, WACC 7.5%, 5yr projection
DCF Exit MultipleGrowth$53.740.97xyesExit EV/EBITDA: 7.9x / 12.9x / 17.9x (bear / base = today's held flat / bull), 5yr
Relative ValuationRelativenoP/S fallback (negative EPS): Sector P/S 1.2x × TTM revenue — excluded from consensus
Simple DDMGrowth$12.214.28xyesDPS $1.62, g=-3.6% (sustainable: ROE (TTM) × retention; not the terminal-growth assumption), ke=9.3%
Two-Stage DDMGrowth$-4.64noStage 1: -173% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAsset$38.301.36xyesReference only (book value floor): BV/sh $38.30, ROE negative
Two-Stage Excess ReturnAsset$34.471.52xyesReference only (book value with convergence): BV/sh $38.30, ROE converges to ke
Discounted Future Market CapGrowth$33.691.55xyesRev $4.0B, growth 0% (input: historical growth; tapered), Terminal P/S: 0.9x / 1.2x / 1.4x (bear / base = today's held flat / bull, cap 6x)
Peter Lynch Fair ValueRelative$0.00noNegative/zero EPS — earnings-based value floored at $0
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$59.730.87xyesNormalized EBIT (5y avg op income, one-time charges added back) $0.63B × (1−21%) / WACC 7.5% → EPV (no growth)
Residual IncomeAssetno
Graham NumberAssetno
EV/EBITDA RelativeRelativenoEBITDA $0.46B × sector EV/EBITDA 6.0x
FCF YieldEarnings$32.331.62xyesFCF $385.0M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarningsno
ROIC-Justified P/BAsset$43.711.19xyesBV $38.30 × (ROIC 8.6% / WACC 7.5%)
P/Sales SectorRelativenoRevenue $3.98B × sector P/S 1.2x
PEG Fair ValueRelativeno
Earnings YieldEarningsno
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

One or more material disclosed units has unresolved economics. Unknown/general is not evidence of homogeneity: segment SOTP is primary but incomplete, consolidated cash flow may remain only a secondary cross-check when every unit shares an enterprise basis, and one sector multiple or target margin is withheld.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
Oil and Natural Gasoperatingenterprise3.0B reported-currencywithheldunresolved no unit value
Carbon Managementoperatingenterprise0.0B reported-currencywithheldunresolved no unit value

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

FieldValue
Net debt$1.3b
Net debt / NOPAT (after-tax)3.28x
Net debt / operating income (pre-tax)2.59x
Share count CAGR (dilution)3.2%
Burning cashno

Leverage and coverage are computed on normalized mid-cycle operating income (mid-cycle margin 16.3%); the trailing year was depressed.

Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.

Bullet Takeaways

Bull Case

Most oil producers compete on geology and cost. This one competes on a permit. California has spent two decades making it progressively harder to drill inside its borders, and the practical consequence is that the incumbent with existing operations, existing approvals and existing infrastructure faces a competitive set that cannot easily expand. The 10-K puts the position plainly: "We are the largest operator in California and currently operate all of our core oil and gas fields." Regulation is usually a cost. Here it is also a moat, and it is the single most important thing to understand about the company.

That moat shows up where a moat should show up, in the margin. Through the cycle the business converts about 16.3 percent of revenue into operating profit. Set that against the cohort of independent producers: CHRD earns a 3.6 percent operating margin, OVV 5.1 percent, CRGY 10.1 percent, MUR 10.7 percent, SM 11.2 percent. Only the gas-weighted names clear it comfortably, with CRK at 30.3 percent, MTDR at 24.4 percent and AR at 23.1 percent. A California operator carrying the highest compliance burden in the country still turns a larger share of each revenue dollar into operating profit than most of the shale complex, which is what a structural position looks like when it reaches the income statement.

The second advantage is that the crude fits the local market. The filing notes that in-state "refineries are generally designed to process crude with characteristics similar to those of our production", and separately that "California imports nearly 95% of its natural gas from other states and Canada". A barrel produced in Kern County does not need to reach the Gulf Coast to find a buyer configured to process it, and the gas sold locally is priced against a market that is structurally short. Both are quiet advantages that never appear in a production headline.

Scale improved recently without a drilling campaign. Production rose 13 MBbl/d, from 111 MBbl/d to 124 MBbl/d, in the first quarter of 2026 against the same quarter a year earlier, and the filing attributes that entirely to the Berry Merger. Buying producing California barrels is currently a cheaper way to add volume than trying to permit new ones, which is a direct consequence of the same regulatory position described above.

Then there is what sits underneath, which the reserve disclosures put a number on. At December 31, 2025 the discounted value of proved reserves, computed on the SEC's prescribed pricing and a 10 percent discount rate, was 8,717 million dollars before future income taxes and 6,666 million dollars after. The filing is careful about what that is: "Standardized measure is prescribed by the SEC as an industry standard asset value measure to compare reserves with consistent pricing, costs and discount assumptions." It is a standardized comparison, not an appraisal, and it moves with the trailing average price used to compute it. But it is the disclosed value of the barrels already booked, and it is larger than the whole enterprise the market is currently pricing.

Carbon storage is the free option on top. The 10-K reports that "As of February 28, 2026, we have eight Class VI UIC project applications related to our carbon management segment pending with the EPA in different stages of the permitting process", with first injection at Elk Hills anticipated in spring 2026 and roughly $15 million of 2026 capital allocated to completing that work. Fifteen million dollars is not a bet, it is a research budget. The same depleted reservoirs and the same subsurface engineers that produced the oil are what a storage business needs, and the state that made drilling hard is the same state pushing hardest for sequestration. If it works, the asset base gets a second revenue life; if it does not, the amount at risk barely registers. The company also intends to fund the year from its own operations, stating "We intend to fund our 2026 capital program using cash flow from operations."

Bear Case

Peak earnings and sustainable earnings are the same argument in a commodity business, and here the two sit on opposite sides of zero. Trailing operating income is negative at $160 million. The figure the price is actually working from is a normalized one near $467 million, built by applying the company's through-the-cycle margin to current revenue rather than using the trough that just occurred. That substitution is defensible practice and it is also the entire thesis. Every conclusion downstream rests on the assertion that the last twelve months were the exception and 16.3 percent is the truth.

The most recent quarter did not help that assertion. The three months ended March 31, 2026 produced a net loss of $711 million, against $12 million of net income in the immediately preceding quarter, with a loss before income taxes of $760 million versus $23 million. The dominant driver was a net loss from commodity sales derivatives of $848 million, against a $126 million gain in the prior quarter. Most of that is a revaluation rather than money leaving, since net settlements on those derivatives came to $68 million in the quarter. But the revaluation is telling you something real: the hedge book is now positioned against the forward curve, which caps what a price recovery can deliver to the income statement in the periods the recovery would arrive.

The demand side of this particular cycle has a California-specific problem the national one does not. The 10-K observes that "In recent periods, certain California refineries and interconnected pipelines have announced closures or reductions in operations, and additional reductions in refining capacity may occur in the future." Read that alongside the advantage described elsewhere in the same filing, that local refineries are configured for this crude, and the two facts collide. The customer base that is uniquely suited to the product is shrinking, and there is no straightforward substitute market for a landlocked California barrel. The company also flags that "Recent and future actions by the State of California could reduce both the demand for and supply of oil and natural gas within the state", and adds that "Local restrictions may be adopted notwithstanding state-level permitting frameworks, and the resulting regulatory landscape may vary significantly by jurisdiction, increasing compliance complexity and uncertainty." The regulatory barrier that keeps competitors out is the same barrier that can be tightened on the incumbent.

The non-oil earnings are also past their high-water mark. On the power side the filing states "We experienced peak pricing for resource adequacy contracts in 2025 as compared to 2024.", and market prices for 2026 contracts declined as more capacity became available. That business had been an offset to commodity weakness. It is now a smaller one.

The balance sheet leaves less room than the mid-cycle framing suggests. Net borrowings run about 1.4 billion dollars against 40 million dollars of liquid assets, which works out to roughly 2.99 times operating profit on the through-the-cycle basis, or 3.78 times measured after tax. On the trailing basis that ratio has no denominator at all. Operating profit covers interest about 4.4 times through the cycle, and the March quarter added a charge for retiring borrowings early on top of the regular interest bill. Meanwhile the share count has risen at roughly 3.1 percent a year over the four years to March 2026, since both recent acquisitions were paid for partly in stock. Equity interests held outside the operating business total about $102 million, a little over two percent of market value, so there is no meaningful cushion there either. Should the through-cycle margin turn out to be an artifact of a better decade rather than a description of this one, the leverage stops being modest very quickly.

Valuation

Strip the accounting noise out and the market is paying about 13 times what this business earns in an average year rather than in this one. That multiple implies company-wide operating profit compounding at roughly 3.7% a year for about five years, which is a pace the company has cleared before. The number should be held loosely: it comes from a single solve at a 9.31 percent cost of capital, and each additional percentage point on that rate moves the implied growth requirement by about 5.7 points. The direction is more informative than the decimal. What the price is asking for is not heroic growth. It is normalization.

The methods split along exactly that line. Approaches that project forward cash generation land above the price, including the one that carries recent free cash flow growth into a terminal value. Peer multiples land essentially on top of it, within a rounding error of the quote. The approaches anchored on recorded book value sit well below, with the price at roughly 1.7 times where they center, and the earnings-power lens that capitalizes current profit with no growth assumed lands between those book-value reads and the quote. Capitalizing $380 million of free cash flow at a 9.3 percent required return with no growth at all, for instance, produces a figure the price sits well above. That is the whole disagreement in one sentence: the forward-looking methods believe the normalization and the backward-looking ones do not.

Against that, the reserve disclosures pull the other way. At December 31, 2025 the discounted value of proved reserves on the SEC's prescribed pricing and a 10 percent rate came to 8,717 million dollars before future income taxes and 6,666 million dollars after, the difference being 2,051 million dollars of discounted future tax. Those figures exceed the enterprise the market is pricing. They are computed on a trailing average price and include undeveloped reserves that still require capital, so they are not an appraisal. But they explain why the book-value approaches read low: historical cost accounting for oil properties bears little relation to what the SEC's own standardized measure says the barrels discount to.

The peer set makes the cyclicality concrete rather than abstract. CRK converts 30.3 percent of revenue into operating profit with revenue up 60.3 percent year over year, while CHRD converts 3.6 percent with revenue down 1.0 percent, and CRGY runs a negative 7.5 percent net margin on 18.3 percent revenue growth. Those are companies producing similar molecules in the same year, and the spread between them is what commodity leverage does to reported results. A single year's number, for this business or any of them, is not a description of the business.

The balance sheet is where the mid-cycle framing gets tested in practice. Net borrowings of about 1.4 billion dollars sit against 40 million dollars of liquid assets, roughly 2.99 times operating profit on the through-the-cycle basis and 3.78 times after tax, with interest covered about 4.4 times. The company states that it intends to fund the 2026 capital program from operations, and the share count has grown at roughly 3.1 percent a year over the four years to March 2026 because the recent acquisitions were paid for in part with equity. What the buyer is holding, then, is a levered claim on a mid-cycle margin that the current year is not producing, backed by a reserve base the SEC's own measure values above the enterprise, in a state whose policy can move either variable.

Catalysts

The carbon business has its first hard checkpoint in months rather than years. The 10-K reports eight Class VI underground injection applications pending with the EPA as of February 28, 2026, with a final decision expected on the permits for the Carbon TerraVault sites and first CO2 injection at Elk Hills anticipated in spring 2026. About $15 million of 2026 capital is earmarked for completing that work. A granted permit and an actual injection would convert a segment that currently consumes a rounding error of capital into one with a demonstrated operating capability, which is a different thing from a stated ambition.

The oil business has a nearer and less pleasant checkpoint. The March 2026 quarter carried a net loss of $711 million on an $848 million net loss from commodity sales derivatives, and the hedge book is the reason a rising forward curve now shows up as a charge rather than a benefit. Production, by contrast, moved the right way, rising to 124 MBbl/d from 111 MBbl/d year over year on the Berry Merger, and the filing notes that "The Berry Merger affected the comparability of our financial results for the three months ended March 31, 2026 to the prior comparative period." The June quarter is the first clean look at the combined asset base without a merger closing inside the comparison.

Two slower items sit behind both. California's in-state refining capacity is contracting, and the company has said additional reductions may occur, which changes who buys the barrel and at what differential. And on the power side, resource adequacy contract pricing peaked in 2025 and 2026 contracts were struck lower as more capacity came available. Neither resolves on an earnings date. Both determine whether the through-cycle margin the price relies on is still the right normal.

Peer Cohorts (Per Segment, With Filing Citations)

Oil and Natural Gas (reported)

Carbon Management (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

CRC FY2025 Form 10-K, carbon management segment

View the full interactive CRC report on boothcheck